Innovest Global Acquires 100% of StemVax Therapeutics

Author's Avatar
Mar 03, 2020
Article's Main Image

Company Acquires Remaining 80% of StemVax Therapeutics - An Emerging Developer of Novel Therapies for Brain Tumor Patients
Innovest Global to Remain Pure Play Industrials Company With Planned Spinoff of StemVax Therapeutics Via Public Listing in Mid-2020